1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Authors

Showing 8 results for author "Ayse Gul Korkmaz".

Back to authors

Thumbnail for Rising Terminal Nutritional-Frailty Vulnerability Despite Declining Overall Multiple Myeloma Mortality: National Trends, Co-Occurring Vulnerability Markers, Place-of-Death Patterns, and Disparities in the United States

MM - 455

Rising Terminal Nutritional-Frailty Vulnerability Despite Declining Overall Multiple Myeloma Mortality: National Trends, Co-Occurring Vulnerability Markers, Place-of-Death Patterns, and Disparities in the United States

Ayse Gul Korkmaz

Poster Presenter: Ayse Gul Korkmaz

$Thumbnail for Reducing Hospitalization During Bispecific Antibody Initiation in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Pooled Analysis of Outpatient, Step-Up, and CRS-Mitigation Strategies$

MM - 574

Reducing Hospitalization During Bispecific Antibody Initiation in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Pooled Analysis of Outpatient, Step-Up, and CRS-Mitigation Strategies

Ayse Gul Korkmaz

Poster Presenter: Ayse Gul Korkmaz

SOHO 2026 Annual Meeting

Authors

Rising Terminal Nutritional-Frailty Vulnerability Despite Declining Overall Multiple Myeloma Mortality: National Trends, Co-Occurring Vulnerability Markers, Place-of-Death Patterns, and Disparities in the United States

Reducing Hospitalization During Bispecific Antibody Initiation in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Pooled Analysis of Outpatient, Step-Up, and CRS-Mitigation Strategies

Post-BCMA Sequencing in Relapsed/Refractory Multiple Myeloma: BCMA Re-Targeting Versus Non-BCMA T-Cell Redirection

Premature Mortality in Early-Onset Multiple Myeloma in the United States, 1999-2024: Trends, Disparities, and Disproportionate Years of Potential Life Lost

Rising Venous Thromboembolism-Associated Mortality Despite Declining Overall Multiple Myeloma Mortality in the United States, 1999-2024: Pulmonary Embolism Burden and Demographic Disparities

Treatment-Limiting On-Target Toxicity With Talquetamab/GPRC5D-Directed Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Generalizability Gaps in BCMA- and GPRC5D-Directed Immunotherapy Trials for Relapsed/Refractory Multiple Myeloma: A Trial-Level Eligibility Analysis

Rising Fall- and Fracture-Associated Mortality Despite Declining Overall Multiple Myeloma Mortality in the United States, 2018-2024: National Trends, Fracture-Site Burden, and Disparities